Skip to content

Astrana Health

US · ASTH #2768 by market cap Listed 1970
37.14 +0.14 +0.38%
Live - 5344 symbols - heartbeat 448s ago · 2026-10-07 19:54
After-hours 37.14 0.00%
Market cap
2.07B
P/B
2.49
EPS
0.46
Reader sentiment Are you bullish or bearish on ASTH?

Anonymous reader poll. Unscientific, not investment advice.

Recent news

  • Rating change
    Jefferies Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $53
    Market Newswire · 2026/6/30
  • Rating change
    TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/7/14
  • Company notice
    Apollo Medical: Apollo Medical Holdings, Inc. - Name/Symbol Change Option Symbol: AMEH New Symbol: ASTH
    OCC · 2024/2/24
  • Company notice
    Apollo Medical: Apollo Medical Holdings, Inc. - Name/Symbol Change Option Symbol: AMEH New Symbol: ASTH
    OCC · 2024/2/24
  • Rating change
    Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $47
    Market Newswire · 2026/5/19
  • Rating change
    Analysts Offer Insights on Healthcare Companies: Oruka Therapeutics (ORKA), Alto Neuroscience, Inc. (ANRO) and Astrana Health (ASTH)
    TipRanks · 2026/7/14
  • Rating change
    BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/6/2
  • Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $55
    Market Newswire · 2026/8/11
  • Rating change
    Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $47
    Market Newswire · 2026/5/14
  • Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating
    Market Newswire · 2026/9/29
  • Rating change
    BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $65
    Market Newswire · 2026/7/14
  • Barclays Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $53
    Market Newswire · 2026/8/28
  • Rating change
    Truist Financial Maintains Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $55
    Market Newswire · 2026/8/11
  • Oppenheimer Initiates Astrana Health(ASTH.US) With Buy Rating, Announces Target Price $53
    Market Newswire · 2026/9/15
  • Rating change
    Barclays Upgrades Astrana Health(ASTH.US) to Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/5/26
  • Freedom Capital Markets Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $50
    Market Newswire · 2026/10/2
  • Rating change
    TD Cowen Maintains Astrana Health(ASTH.US) With Buy Rating, Raises Target Price to $50
    Market Newswire · 2026/7/14
  • Rating change
    BTIG Maintains Astrana Health(ASTH.US) With Buy Rating, Maintains Target Price $65
    Market Newswire · 2026/8/10
  • Rating change
    Analysts Are Bullish on These Healthcare Stocks: Astrana Health (ASTH), ArriVent BioPharma, Inc. (AVBP)
    TipRanks · 2026/7/14
  • Rating change
    A Quick Look at Today's Ratings for Astrana Health(ASTH.US), With a Forecast Between $41 to $53
    Market Newswire · 2026/8/8

Headlines are aggregated automatically and are not independently verified or edited by our team.

Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.